Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 1325
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02406521 | Exploratory Study of Radium-223 and VEGF-Targeted Therapy in Patients With Metastatic Renal Cell Carcinoma and Bone Mets | ||
| NCT04908852 | Feasibility Pilot Exploring Variability in Biomarkers and PROs in AML | ||
| NCT00165230 | Thalidomide in Combination With Temodar in Patients With Neuroendocrine Tumors | ||
| NCT03331406 | Physical Activity In Gastrointestinal Cancer | ||
| NCT00976898 | Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer and Cholangiocarcinoma | ||
| NCT00140504 | Preventing Adverse Drug Events With PatientSite | ||
| NCT02724904 | Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplant (HSCT) For Lymphoma | ||
| NCT02439138 | Study of Phosphatidylinositol-3-kinase (PI3K) Inhibitor Idelalisib (GS-1101) in Waldenström Macroglobulinemia | ||
| NCT03777410 | Mass Accumulation Rate (MAR) as a Predictive Biomarker in Multiple Myeloma | ||
| NCT00307723 | Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer | ||
| NCT02658396 | GO-203-2C + Bortezomib For Relapsed Or Refractory MM | ||
| NCT01568346 | Breast MRI for Newly Diagnosed Breast Cancer:Impact on Re-excision Lumpectomy | ||
| NCT01659203 | Proton or Photon RT for Retroperitoneal Sarcomas | ||
| NCT04789486 | Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer | ||
| NCT04497142 | Effect of Perampanel on Peritumoral Hyperexcitability in HGG | ||
| NCT04569747 | A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer | ||
| NCT01754025 | INHERIT EGFR - Studying Germline EGFR Mutations | ||
| NCT04781374 | Neratinib in Patients With Metastatic Castration-Resistant Prostate Cancer | ||
| NCT00136474 | Amifostine for Head and Neck Irradiation in Lymphoma | ||
| NCT03436654 | Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic Adenocarcinoma | ||
| NCT05774886 | Implantable Microdevice for TNBC - Pilot Study | ||
| NCT00137813 | Avastin and Taxotere for Esophagogastric Cancer | ||
| NCT02675959 | Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease | ||
| NCT00095927 | Randomized Amifostine For SCCHN | ||
| NCT01642186 | Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC) | ||
| NCT01024387 | AMG 479 in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors | ||
| NCT00307736 | Bevacizumab, Erlotinib and 5-Fluorouracil With External Beam Radiation Therapy in Locally Advanced Rectal Cancer | ||
| NCT00548236 | The Active After Cancer Trial (AACT) | ||
| NCT07397611 | Pre-NEOSHIFT-RCC: Neoadjuvant HIF-Inhibitor Immunotherapy in RCC | ||
| NCT03410875 | A Phase II Study of the BRAF Inhibitor, Vemurafenib, Plus Obinutuzumab in Patients With Previously Untreated Classical Hairy Cell Leukemia | ||
| NCT02282722 | Improving Informed Consent for Palliative Chemotherapy | ||
| NCT00119730 | Chemotherapy Followed by Zevalin for Relapsed Mantle Cell Lymphoma | ||
| NCT00355407 | Darbepoetin Alfa (Aranesp) Following Allogeneic Stem Cell Transplantation | ||
| NCT06318871 | Memory-like Natural Killer (NK) Cell Therapy in Patients With Renal Cell Carcinoma or Urothelial Carcinoma | ||
| NCT01009788 | ABT-888 and Temozolomide for Metastatic Breast Cancer and BRCA1/2 Breast Cancer | ||
| NCT00593060 | Temsirolimus (CCI-770, Torisel) Combined With Cetuximab in Cetuximab-Refractory Colorectal Cancer | ||
| NCT02644382 | Improving Surgical Decision-making in Young Women With Breast Cancer | ||
| NCT02977780 | INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT) | ||
| NCT05011279 | Move Together Boston Feasibility Pilot (Sit Less, Move More App for Black Breast Cancer Survivors & At-Risk Relatives) | ||
| NCT04416568 | Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers | ||
| NCT01860937 | T-Lymphocytes Genetically Targeted to the B-Cell Specific Antigen CD19 in Pediatric and Young Adult Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia | ||
| NCT02127359 | Whole-Exome Sequencing (WES) of Cancer Patients | ||
| NCT03170206 | Study of Palbociclib in Combination With Binimetinib for Patients With Advanced KRAS Mutant Non-Small Cell Lung Cancer | ||
| NCT00821080 | Vandetanib and Sirolimus in Patients With Recurrent Glioblastoma | ||
| NCT03514680 | Clinician Decision Support Algorithm for Chemotherapy-Induced Peripheral Neuropathy | ||
| NCT06479187 | PSMAtrack-tracking Changes in PSMA-PET During Initial Therapy for Metastatic Hormone-sensitive Prostate Cancer | ||
| NCT01491633 | Dasatinib in Advanced Squamous Cell Lung Cancer | ||
| NCT04839614 | Concurrent Laparoscopic Hysterectomy and Weight Loss Surgery in Obese Patients With Endometrial Carcinoma or Endometrial Intraepithelial Neoplasia | ||
| NCT06422455 | Access to Genetic Testing in Underserved Patients With Cancer | ||
| NCT04620187 | Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas |
